Yeah with 5000 capacity. They are prescribing, "in addition", for their clinical trials, too. So not all of it will be revenue generating. What is exciting though, is that we could see this company become profitable before full marketing authorisation.
- Forums
- ASX - By Stock
- Ann: 800 Prescription Milestone Passed for MGC Pharma Products
Yeah with 5000 capacity. They are prescribing, "in addition",...
Featured News
Add RGT (ASX) to my watchlist
(20min delay)
|
|||||
Last
29.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.73M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 4408 | 25.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
29.0¢ | 1899 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 4408 | 0.250 |
1 | 2200 | 0.230 |
1 | 14900 | 0.220 |
1 | 16950 | 0.200 |
1 | 5588 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.290 | 1899 | 2 |
0.305 | 2073 | 2 |
0.310 | 50 | 1 |
0.320 | 50 | 1 |
0.325 | 3069 | 1 |
Last trade - 16.12pm 08/11/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
Day chart unavailable
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online